postoperative care after laser
Conditions
Interventions
Group 2:Use mask after pico1064nm laser
Group 1:Use marigold moisturizing spray and mask after pico1064nm laser
Sponsors
9th People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Age from 18 to 65, no gender limitation (2) In good health, no history of serious diseases of cardiovascular system, digestive system, endocrine system, immune system, nervous system or other major diseases;No history of mental or psychological disorders (3) In line with the indications of pico1064nm treatment, such as acne scar, light aging, enlarged pores, etc (4) No skin barrier damage, no obvious telangiectasia, chloasma, etc (5) The subjects fully understand the test contents, voluntarily participate in the test, and have signed the informed consent form (6) No history of skin chemical peeling, other photoelectric treatment history, or participation in other clinical studies affecting the observation of this study within 3 months (7) No history of drug allergy, skin tumor, dermatitis, eczema and other skin diseases (8) Be able to conduct treatment, data collection and visit cooperation according to research requirements
Exclusion criteria
Exclusion criteria: (1) Known to be allergic to the active ingredients or excipients of the cosmetics under study (2) Facial skin with obvious signs of bacterial, fungal, viral or other pathogen infection, such as acne, folliculitis, herpes simplex, verruca plana, etc (3) Previous history of herpes simplex (4) During pregnancy, pregnancy and lactation (5) Those who use Chinese herbal medicine, sleeping sedatives or other addictive drugs (6) Alcoholics, patients with mental illness, or those who cannot cooperate with the treatment and researchers according to the doctor's advice (7) Patients with a history of photosensitive diseases (chronic actinic dermatitis, systemic lupus erythematosus, etc.), skin photoallergy, porphyrin allergy, porphyria, etc (8) Oral or external photosensitive drugs or hormones
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| transepidermal water loss ( TEWL) ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction;Adverse reaction rate; | — |
Countries
China
Contacts
Public ContactDong jiying
Outcome results
None listed